HomeCTX • TSE
add
Crescita Therapeutics Inc
Previous close
$0.45
Year range
$0.40 - $0.61
Market cap
8.28M CAD
Avg Volume
24.71K
P/E ratio
18.22
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 5.39M | 50.06% |
Operating expense | 3.02M | -3.89% |
Net income | 753.00K | 172.68% |
Net profit margin | 13.96 | 148.42% |
Earnings per share | — | — |
EBITDA | 222.00K | 125.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.31M | -1.54% |
Total assets | 21.46M | -5.41% |
Total liabilities | 5.20M | -21.47% |
Total equity | 16.26M | — |
Shares outstanding | 18.61M | — |
Price to book | 0.51 | — |
Return on assets | -1.87% | — |
Return on capital | -2.46% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 753.00K | 172.68% |
Cash from operations | 1.17M | 176.65% |
Cash from investing | -821.00K | -8.89% |
Cash from financing | -239.00K | -5.29% |
Net change in cash | 124.00K | 121.60% |
Free cash flow | -1.58M | -6,012.08% |
About
Founded
2016
Website
Employees
75
